These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29497467)

  • 1. Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic Review.
    Mangion K; McDowell K; Mark PB; Rutherford E
    Curr Cardiovasc Imaging Rep; 2018; 11(1):2. PubMed ID: 29497467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Magnetic Resonance Imaging Findings in Patients With Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.
    Chandramohan D; Rajasekaran R; Konda R; Pujari A; Avula S; Bell M; Palleti SK; Deotare A; Naik R; Bali A; Simhadri P; Arora H; Jena N
    Cureus; 2024 Jan; 16(1):e51672. PubMed ID: 38313918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance.
    Arcari L; Engel J; Freiwald T; Zhou H; Zainal H; Gawor M; Buettner S; Geiger H; Hauser I; Nagel E; Puntmann VO
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):71. PubMed ID: 34092229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study.
    Hayer MK; Radhakrishnan A; Price AM; Liu B; Baig S; Weston CJ; Biasiolli L; Ferro CJ; Townend JN; Steeds RP; Edwards NC;
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2357-2367. PubMed ID: 32682713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine Metabolites as Biomarkers of Myocardial Ischaemia, Assessed with Cardiac Magnetic Resonance Imaging in Chronic Kidney Disease.
    Shah RJ; Tommasi S; Faull R; Gleadle JM; Mangoni AA; Selvanayagam JB
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining Biventricular Abnormalities by Cardiac Magnetic Resonance in Pre-Dialysis Patients with Chronic Kidney Disease.
    Qi L; Zhi B; Zhang J; Zhang L; Luo S; Zhang L
    Kidney Dis (Basel); 2023 Aug; 9(4):277-284. PubMed ID: 37900003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease.
    Parnham S; Gleadle JM; Bangalore S; Grover S; Perry R; Woodman RJ; De Pasquale CG; Selvanayagam JB
    J Am Heart Assoc; 2015 Aug; 4(8):e002249. PubMed ID: 26260054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age and chronic kidney disease on regional aortic distensibility: a cardiovascular magnetic resonance study.
    Chue CD; Edwards NC; Ferro CJ; Townend JN; Steeds RP
    Int J Cardiol; 2013 Oct; 168(4):4249-54. PubMed ID: 22959867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease is related to impaired left ventricular strain as assessed by cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy.
    Dettori R; Milzi A; Lubberich RK; Burgmaier K; Reith S; Marx N; Frick M; Burgmaier M
    Clin Res Cardiol; 2023 Dec; ():. PubMed ID: 38078956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy.
    Arcari L; Hinojar R; Engel J; Freiwald T; Platschek S; Zainal H; Zhou H; Vasquez M; Keller T; Rolf A; Geiger H; Hauser I; Vogl TJ; Zeiher AM; Volpe M; Nagel E; Puntmann VO
    Int J Cardiol; 2020 May; 306():102-108. PubMed ID: 32169347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging.
    Cheang MH; Barber NJ; Khushnood A; Hauser JA; Kowalik GT; Steeden JA; Quail MA; Tullus K; Hothi D; Muthurangu V
    J Cardiovasc Magn Reson; 2018 Mar; 20(1):24. PubMed ID: 29609642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.
    Alabed S; Garg P; Johns CS; Alandejani F; Shahin Y; Dwivedi K; Zafar H; Wild JM; Kiely DG; Swift AJ
    Curr Cardiovasc Imaging Rep; 2020; 13(12):30. PubMed ID: 33184585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping.
    Haslbauer JD; Lindner S; Valbuena-Lopez S; Zainal H; Zhou H; D'Angelo T; Pathan F; Arendt CA; Bug G; Serve H; Vogl TJ; Zeiher AM; Carr-White G; Nagel E; Puntmann VO
    Int J Cardiol; 2019 Jan; 275():179-186. PubMed ID: 30360992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Adverse Remodeling in Ischemic Heart Disease: Emerging Cardiac Magnetic Resonance Imaging Biomarkers.
    Calvieri C; Riva A; Sturla F; Dominici L; Conia L; Gaudio C; Miraldi F; Secchi F; Galea N
    J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.
    Poindron V; Chatelus E; Canuet M; Gottenberg JE; Arnaud L; Gangi A; Gavand PE; Guffroy A; Korganow AS; Germain P; Sibilia J; El Ghannudi S; Martin T
    Semin Arthritis Rheum; 2020 Feb; 50(1):128-134. PubMed ID: 31301817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMR T
    Zhao P; Huang L; Ran L; Tang D; Zhou X; Xia L
    Eur Radiol; 2021 Mar; 31(3):1206-1215. PubMed ID: 32876836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased left ventricular myocardial extracellular volume is associated with longer cardiopulmonary bypass times, biventricular enlargement and reduced exercise tolerance in children after repair of Tetralogy of Fallot.
    Riesenkampff E; Luining W; Seed M; Chungsomprasong P; Manlhiot C; Elders B; McCrindle BW; Yoo SJ; Grosse-Wortmann L
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):75. PubMed ID: 27782857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.